NCT06592092View on ClinicalTrials.gov

Clinical Study of QH104 Cell Injection for the Treatment of Meningeal Metastases of B7H3+ Solid Tumors

NARecruitingINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

April 1, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2027

Conditions
Solid TumorMeningeal Metastasis
Interventions
BIOLOGICAL

QH104 Cell injection

Patients will first be pre-screened for B7H3 expression of tumor and exist Meningeal Metastases.

Trial Locations (2)

100021

RECRUITING

Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing

RECRUITING

Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing

All Listed Sponsors
lead

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

OTHER